Contact

Join Us
Careers

Join us

Collaborative Research

Joint research leveraging TCUBEit’s
T-cell expansion technology and next-generation immunotherapy pipeline.

License In/Out

Technology transfer and exclusive/
non-exclusive licensing of TCUBEit’s
T-cell therapy platform and pipeline innovations.

Joint Venture

Establishment of joint ventures based on TCUBEit’s proprietary T-cell platform
and immunotherapy pipeline.

Information

    Consent to collection of personal information *

    Purpose of Processing Personal Information TCUBEit processes personal information for the following purposes.

    The collected information will not be used for any purpose other than those stated below.
    If the purpose of use changes, TCUBEit will obtain prior consent in accordance with Article 18 of the Personal Information Protection Act.

    • To verify user identity

    • To process and confirm service requests or inquiries

    • To contact users for fact-checking, notifications, and delivery of results

    Items Collected Name, contact information (phone number), email address, and other information necessary for processing requests.

    Retention Period Personal information will be retained for 3 years from the date of collection, after which it will be securely destroyed.